Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Prelay (Troglitazone) Tablets Sankyo U.S.A. NDA 20-719/S012 Rezulin (troglitazone) Tablets, 200mg, 300mg, & 400mg, only Parke-Davis NDA 20-720/ S-012 /S-014 6/16/99 6/17/99 6/17/99 7/3/00 Rezulin Indication: Supplement 012 provides for the use of Rezulin in combination with metformin and sulfonylures in patients with type 2 diabetes. Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.